Fact-checked by Grok 2 weeks ago

Pendrin

Pendrin is an anion exchanger protein encoded by the SLC26A4 gene on chromosome 7q22.3, consisting of 780 amino acids with 11–12 transmembrane domains and functioning as a homodimer to facilitate electroneutral exchange of chloride (Cl⁻) for bicarbonate (HCO₃⁻) or iodide (I⁻) ions across epithelial cell membranes.^[1]^[2] Primarily expressed in the apical membrane of thyroid follicular cells, inner ear endolymphatic sac cells, renal B-intercalated cells in the cortical collecting duct, and airway serous cells, pendrin plays critical roles in ion homeostasis, including iodide efflux for thyroid hormone synthesis, endolymph pH and volume regulation for hearing, renal acid-base balance and chloride reabsorption, and airway mucociliary clearance.^[3]^[1]^[2] Mutations in SLC26A4, often resulting in loss-of-function, cause Pendred syndrome, an autosomal recessive disorder characterized by sensorineural hearing loss due to inner ear malformations such as enlarged vestibular aqueduct and thyroid goiter from impaired iodide efflux, accounting for 7.5–15% of cases of congenital or prelingual sensorineural hearing loss.^[1]^[2]^[4] In the kidney, pendrin ablation leads to hypercalciuria, metabolic alkalosis during volume depletion, and protection against salt-sensitive hypertension by reducing sodium chloride reabsorption in coordination with the Na⁺-Cl⁻ cotransporter (NCC), as evidenced by double-knockout models showing severe salt wasting and renal failure.^[3]^[5] Structurally, pendrin features two anion-binding sites resolved by cryo-electron microscopy at 2.5–2.8 Å resolution, with the C-terminal STAS domain regulating transport activity, and it serves as a potential therapeutic target for inhibition by small molecules like niflumic acid (IC₅₀ ≈ 15 µM) in conditions involving excessive anion exchange.^[2]

Molecular Biology

Gene

The SLC26A4 gene, responsible for encoding the pendrin protein, was discovered in 1997 through positional cloning and linkage analysis in families affected by Pendred syndrome, identifying it as a putative sulfate transporter gene mutated in the disorder.^[6] This autosomal recessive condition links biallelic mutations in SLC26A4 to syndromic hearing loss and thyroid dysfunction, marking a key advancement in understanding genetic causes of such phenotypes.^[7] In humans, SLC26A4 is located on the long arm of chromosome 7 at cytogenetic band 7q22.3, spanning genomic coordinates 107,660,594–107,717,809 (forward strand) in the GRCh38/hg38 assembly, which covers approximately 57 kb of DNA.^[8] The gene comprises 21 exons, including a non-coding first exon, with the coding sequence distributed across the remaining exons to produce the full-length transcript.^[9] Alternative splicing generates multiple isoforms, with at least 11 transcript variants reported, potentially contributing to tissue-specific functions of the encoded protein.^[8] Expression of SLC26A4 is primarily observed in the thyroid gland, inner ear, and kidney, where it supports anion transport processes essential for physiological homeostasis.^[10] Transcriptional regulation involves factors like FOXI1, a winged-helix transcription factor that binds directly to the SLC26A4 promoter, activating expression in relevant tissues such as the kidney and inner ear.^[11] Evolutionarily, SLC26A4 belongs to the SLC26/SulP family of anion transporters, which is highly conserved from bacteria and plants—where SulP homologs function in sulfate uptake—to mammals, retaining core motifs like the STAS domain for regulatory interactions.^[12] Mammalian orthologs, including those in mice and rats, share over 80% sequence identity in key functional regions, underscoring the gene's preservation across vertebrate lineages.^[13]

Protein Structure

Pendrin, encoded by the SLC26A4 gene, is a 780-amino acid polytopic membrane protein with a predicted molecular mass of approximately 86 kDa and belongs to the solute carrier 26 (SLC26) family of anion transporters.^[14]^[15] It features a topology with 14 transmembrane helices that span the plasma membrane, forming a central pore for anion translocation, along with intracellular N- and C-terminal domains.^[16]^[17]^[18] A key structural element is the C-terminal sulfate transporter and anti-sigma factor antagonist (STAS) domain, which spans approximately 130-140 amino acids and plays a regulatory role in anion transport function, protein stability, and interactions with regulatory proteins.^[12] The transmembrane helices, particularly those in the core bundle (TM1-4, 8-11), contribute to substrate specificity and the formation of the anion-binding sites within the translocation pathway. Cryo-EM structures at 2.5–3.0 Å resolution reveal two anion-binding sites (S1 and S2) within the TMD, facilitating the exchange mechanism, with the protein adopting inward-facing conformations in a homodimeric assembly.^[18]^[2] Recent structural studies have revealed that pendrin forms an asymmetric homodimer, with the STAS domain modulating the conformational changes necessary for transport.^[18] Post-translational modifications are essential for pendrin's maturation and function. It undergoes N-linked glycosylation at two utilized sites (Asn¹⁶⁷ and Asn¹⁷² in the second extracellular loop), with additional predicted but non-utilized sites, which facilitate proper folding, trafficking to the plasma membrane, and stability without directly altering transport kinetics.^[19]^[20] Additionally, pendrin is subject to phosphorylation by protein kinase A (PKA) at serine residues in its cytoplasmic domains, which enhances its membrane abundance and anion exchange activity in response to hormonal signals.^[21] The transport mechanism of pendrin involves electroneutral 1:1 anion exchange, primarily mediating the efflux of bicarbonate (HCO₃⁻), iodide (I⁻), or formate in exchange for chloride (Cl⁻) influx, with activity that is highly sensitive to extracellular pH—optimal at acidic conditions (pH ~6.5-7.0) and inhibited at higher pH.^[22] This pH dependence arises from protonation states influencing anion binding and conformational gating within the transmembrane pore.^[2] Pendrin exhibits significant sequence homology to other SLC26 family members, sharing about 40-50% identity in transmembrane and STAS domains with SLC26A3 (downregulated in adenoma, DRA), an intestinal Cl⁻/HCO₃⁻ exchanger, and sulfate transporters like SLC26A2, reflecting a conserved architecture for anion recognition and translocation across the family.^[17]^[23]

Physiological Functions

Thyroid Gland

Pendrin, encoded by the SLC26A4 gene, is localized to the apical membrane of thyroid follicular cells, known as thyrocytes, where it plays a crucial role in facilitating the efflux of iodide ions (I⁻) into the thyroid colloid.^[24] This positioning allows pendrin to mediate the final step in iodide translocation across the thyrocyte, ensuring availability for subsequent biosynthetic processes.^[25] The primary mechanism of pendrin in the thyroid involves electroneutral anion exchange, specifically Cl⁻/I⁻ exchange, which exports iodide from the cytoplasm into the follicular lumen in exchange for chloride ions.^[25] This process is tightly coupled with the basolateral sodium-iodide symporter (NIS), which actively accumulates iodide into the thyrocyte from the bloodstream; together, they enable vectorial iodide transport essential for organification.^[26] Pendrin's anion exchange capability, which supports this iodide-specific function, underpins its broader role as a multifaceted transporter.^[2] By delivering iodide to the colloid, pendrin ensures its availability for iodination of thyroglobulin, catalyzed by thyroid peroxidase (TPO), thereby integrating into the thyroid hormone synthetic pathway.^[25] This interaction with TPO is indirect but vital, as pendrin-supplied iodide serves as the substrate for TPO-mediated oxidation and coupling reactions that form monoiodotyrosine (MIT) and diiodotyrosine (DIT) residues on thyroglobulin, precursors to triiodothyronine (T3) and thyroxine (T4).^[27] Physiologically, pendrin contributes to efficient thyroid hormone (T3 and T4) production by optimizing iodide handling within the gland; its disruption impairs organification and hormone synthesis, often resulting in goiter due to compensatory thyroid enlargement.^[25] Experimental evidence from pendrin (Slc26a4) knockout mouse models demonstrates reduced apical iodide efflux, leading to diminished overall iodide accumulation in the thyroid and signs of hypothyroidism, particularly under iodine-deficient conditions.^[28] In these models, iodine restriction causes significant decreases in serum total thyroxine (TT4) levels (e.g., from approximately 5.25 μg/dL on control diet to 3.11 μg/dL on deficient diet) and elevated thyroid-stimulating hormone (TSH), alongside structural changes like increased thyrocyte size and reduced colloidal area, though overt goiter may not always develop.^[28]^[25]

Inner Ear

Pendrin, encoded by the SLC26A4 gene, is localized to the apical membrane of marginal cells in the stria vascularis and spindle-shaped (root) cells within the cochlea of the inner ear.^[29] These non-sensory epithelial cells position pendrin to interface directly with endolymph, the potassium-rich extracellular fluid surrounding sensory hair cells.^[30] In these locations, pendrin primarily functions as a chloride-bicarbonate (Cl⁻/HCO₃⁻) exchanger, secreting HCO₃⁻ into the endolymph to regulate its pH and support overall fluid homeostasis.^[30] This activity contributes to maintaining the endocochlear potential, a positive voltage gradient of approximately +80 mV relative to perilymph, which is essential for auditory transduction.^[31] Pendrin's anion exchange properties enable this role, facilitating ion balance without direct involvement in chloride secretion.^[32] Developmentally, pendrin is crucial for inner ear morphogenesis, with expression beginning around embryonic day 11.5 in the endolymphatic sac and extending to the cochlea by embryonic day 14.5.^[30] Mutations in SLC26A4 disrupt this process, leading to structural abnormalities such as enlarged vestibular aqueduct (EVA), a hallmark of inner ear malformation.^[31] Evidence from pendrin-null (Slc26a4⁻/⁻) mouse models demonstrates that its absence results in severe fluid imbalance, characterized by endolymphatic volume expansion and acidification, accompanied by deafness and vestibular dysfunction.^[30] These models reveal pendrin's necessity for proper endolymph composition during early postnatal development, with dramatic luminal enlargement compared to wild-type controls.^[31] Within the stria vascularis, pendrin interacts indirectly with other ion transporters, such as the KCNQ1 potassium channel, to facilitate potassium recycling and sustain the high endolymphatic potassium levels required for sensory function.^[32] This coordinated transport supports the electrochemical gradients generated by the stria vascularis.^[29]

Kidney

Pendrin (SLC26A4), an anion exchanger, is primarily localized to the apical membrane of β-intercalated cells (type B and non-A, non-B intercalated cells) in the cortical collecting duct (CCD), as well as the connecting tubule (CNT) and the distal portion of the distal convoluted tubule (DCT) in the rodent kidney. This positioning enables pendrin to mediate anion transport at the luminal surface of these specialized epithelial cells, which are key players in renal electrolyte handling.^[33] In its mechanism of action, pendrin functions as an electroneutral Cl⁻/HCO₃⁻ exchanger, facilitating the apical secretion of bicarbonate (HCO₃⁻) in exchange for chloride (Cl⁻) reabsorption from the tubular lumen. This exchange activity couples with the vacuolar H⁺-ATPase on the same apical membrane, which secretes protons (H⁺), thereby promoting net acid excretion and HCO₃⁻ generation within the cell for systemic delivery.^[33] The process also supports Cl⁻ recovery, often in coordination with basolateral transporters like the Na⁺-dependent Cl⁻/HCO₃⁻ exchanger (NDCBE), contributing to overall NaCl homeostasis without direct Na⁺ coupling in pendrin itself. Physiologically, pendrin plays a crucial role in maintaining systemic pH balance and extracellular fluid volume, particularly during conditions of metabolic alkalosis, where it enhances HCO₃⁻ secretion to counteract elevated blood pH. It is upregulated in response to acidosis, aiding in the kidney's adaptive acid-base regulation, and helps preserve Cl⁻ levels under dietary restriction or alkalotic stress, thereby supporting blood pressure stability through indirect modulation of sodium channels like ENaC.^[33] Evidence from pendrin knockout mouse models demonstrates its importance: these animals exhibit mild metabolic alkalosis at baseline, impaired Cl⁻ reabsorption, reduced ability to correct alkalotic states, and lower ENaC abundance, but lack overt defects in basal acid-base handling. For instance, pendrin-null mice show chloriuresis and natriuresis, highlighting pendrin's role in fine-tuning anion balance without being essential for routine function.^[34] Pendrin expression and activity are regulated by aldosterone, which upregulates it via the mineralocorticoid receptor (MR) through dephosphorylation at serine 843, and by low dietary chloride intake, which stimulates apical targeting. Additional regulators include angiotensin II and metabolic alkalosis, while pendrin interacts functionally with AE1 (SLC4A1) in the renal interstitium, where AE1's basolateral Cl⁻/HCO₃⁻ exchange in α-intercalated cells complements pendrin's apical role in β-intercalated cells to achieve coordinated anion handling across cell types.^[33]

Other Tissues

Pendrin, encoded by the SLC26A4 gene, is expressed at lower levels in various non-primary tissues compared to its prominent expression in the thyroid and kidney, where it plays major roles in anion transport. Quantitative analyses indicate high pendrin abundance in thyroid follicular cells, moderate to high levels in renal intercalated cells, and significantly reduced expression in other sites such as airways and brain, often detectable only through sensitive techniques like RT-PCR or immunohistochemistry.^[35]^[36] In the airways, pendrin is localized to the apical membrane of bronchial epithelial cells, where it functions as a Cl⁻/HCO₃⁻ exchanger to regulate airway surface liquid pH, thereby supporting mucociliary clearance. This exchange activity contributes to bicarbonate secretion, which neutralizes acidic environments and maintains optimal conditions for ciliary function in the respiratory tract.^[37]^[38] Expression of pendrin in these cells is inducible by inflammatory cytokines, such as IL-13, which upregulates its transcription and trafficking to the cell surface during Th2-driven responses.^[39]^[40] Pendrin expression has been detected in the brain, including fetal brain tissue, albeit at lower levels than in thyroid or kidney, suggesting a minor role in central nervous system anion homeostasis. Emerging evidence points to a potential involvement in cerebrospinal fluid pH regulation and anion transport across the blood-CSF barrier, possibly through interactions with other SLC26 family members in choroid plexus epithelia.^[35]^[41] In salivary glands, pendrin is expressed in ductal epithelial cells and participates in electroneutral Cl⁻/I⁻/HCO₃⁻ exchange, contributing to local ion homeostasis by facilitating iodide and bicarbonate secretion into saliva. Similarly, low-level expression occurs in prostate epithelial cells, where it may support prostatic fluid composition through anion exchange, though its precise physiological impact remains under investigation.^[42]^[43] Pendrin is expressed in epididymal epithelial cells (e.g., clear cells), where it may contribute to ion homeostasis in the reproductive tract.^[44]^[45]

Clinical Significance

Pendred Syndrome

Pendred syndrome is an autosomal recessive disorder primarily characterized by sensorineural hearing loss and goiter due to dysfunction in iodide transport in the thyroid and ion homeostasis in the inner ear.^[10] It was first described in 1896 by British physician Vaughan Pendred, who reported cases of congenital deafness associated with thyroid enlargement in siblings.^[4] The prevalence is estimated at 7.5 to 10 per 100,000 live births, accounting for approximately 7.5% to 15% of congenital sensorineural hearing loss cases.^[4] The genetic basis involves biallelic pathogenic variants in the SLC26A4 gene, which encodes the pendrin protein, an anion exchanger critical for chloride, bicarbonate, and iodide transport.^[10] Over 600 variants have been identified as of 2025, including missense mutations, small deletions, and splice site alterations; common examples include p.T416P in European populations, while c.919-2A>G (IVS7-2A>G) and p.H723R predominate in East Asian cohorts.^[46] ^[47] ^[48] These mutations lead to impaired pendrin function, with variable penetrance observed, as not all individuals with biallelic variants develop the full syndromic phenotype.^[10] Pathophysiologically, Pendred syndrome features a thyroid iodide organification defect, where pendrin's role in iodide efflux to the follicular lumen is compromised, resulting in a positive perchlorate discharge test that confirms abnormal iodine trapping.^[4] In the inner ear, defective pendrin disrupts endolymph pH regulation and fluid balance, often leading to malformations such as enlarged vestibular aqueduct (EVA), which contributes to cochlear degeneration and hearing loss.^[10] Clinically, the syndrome manifests with bilateral, prelingual sensorineural hearing loss that is severe to profound in 80-90% of cases, typically evident by age 3, alongside vestibular symptoms like imbalance in about 66% of patients.^[4] Goiter develops in 50-80% of affected individuals, usually during late childhood or adolescence, and is typically euthyroid, though hypothyroidism may occur in iodine-deficient regions.^[10] Diagnosis relies on a combination of genetic testing to identify biallelic SLC26A4 variants, thyroid function tests including the perchlorate discharge test, and imaging such as CT or MRI to detect EVA or other inner ear anomalies.^[4] Audiometric evaluation confirms the hearing loss pattern, and clinical correlation with family history supports the autosomal recessive inheritance.^[10]

Other Disorders and Associations

Pendrin (SLC26A4) has been implicated in several conditions beyond the classic presentation of Pendred syndrome, particularly in airway diseases where its expression is upregulated during allergic inflammation. In asthma, interleukin-13 (IL-13) induces pendrin expression in airway epithelial cells, leading to enhanced anion exchange that promotes mucus hypersecretion and airway hyperreactivity.^[49] This mechanism positions pendrin as a mediator of Th2-driven responses, with studies showing that pendrin knockout reduces mucus production in murine models of allergic airway disease.^[50] Similarly, pendrin expression is elevated in chronic obstructive pulmonary disease (COPD), contributing to excessive mucus and inflammation in the airways, as observed in patient tissues and animal models.^[2] In renal contexts, mutations in SLC26A4 rarely lead to isolated sensorineural deafness combined with renal tubular acidosis, particularly in compound heterozygous individuals, though routine kidney dysfunction is not a feature of Pendred syndrome.^[51] Pendrin's role in bicarbonate secretion in the cortical collecting duct suggests its involvement in acid-base homeostasis, but clinical renal phenotypes remain uncommon and typically mild.^[10] Thyroid-specific phenotypes without hearing loss have been reported in cases of homozygous SLC26A4 mutations, manifesting as non-syndromic goiter or congenital hypothyroidism due to impaired iodide efflux.^[52] These isolated thyroid defects highlight pendrin's critical function in iodide transport, with affected individuals showing euthyroid goiter or mild hypothyroidism responsive to levothyroxine.^[53] Epidemiological studies reveal varying frequencies of SLC26A4 variants across populations, with higher prevalence of deafness-associated alleles in East Asian cohorts, where up to 65-95% of enlarged vestibular aqueduct (EVA) cases involve SLC26A4 mutations compared to lower rates in European populations.^[54] Common variants like c.919-2A>G exhibit allele frequencies exceeding 60% in some Asian groups with EVA, underscoring population-specific genetic risks.^[55]

Research Directions

Recent Advances

Recent structural studies utilizing cryo-electron microscopy (cryo-EM) have provided detailed insights into the architecture of pendrin (SLC26A4), a member of the SLC26A family of anion transporters. In 2023, researchers determined the cryo-EM structures of mouse pendrin in both symmetric and asymmetric homodimer conformations, revealing key features such as the dimerization interface and dynamic pore regions that facilitate anion exchange.^[18] These findings elucidate the molecular basis of pendrin's transport mechanism, including how conformational asymmetry may regulate substrate binding and translocation.^[18] Building on this, a 2024 study further characterized the anion exchange process and identified small-molecule inhibitors targeting the transport domain, highlighting pore dynamics essential for chloride-bicarbonate swapping.^[2] Functional investigations post-2017 have advanced understanding of pendrin's regulatory mechanisms, particularly its sensitivity to environmental cues. Complementary work in 2024 explored the electromechanical properties across the SLC26 family, showing that pendrin exhibits electroneutral exchange but shares gating motifs with family members, informed by mutagenesis and electrophysiological recordings.^[56] Genetic research has expanded the catalog of SLC26A4 variants associated with hearing loss and related phenotypes. As of early 2025, the ClinVar database lists approximately 600 pathogenic or likely pathogenic variants in SLC26A4, reflecting increased genomic sequencing efforts and submissions from diverse populations.^[57] Recent studies indicate that while biallelic mutations predominate in classic Pendred syndrome, incomplete penetrance and modifier effects contribute to polygenic risk for enlarged vestibular aqueduct (EVA), with novel loci identified in multiethnic cohorts.^[58] For instance, a 2025 analysis uncovered additional genetic determinants beyond SLC26A4 that influence EVA severity in central European populations.^[58] In August 2025, cryo-EM structures of human SLC26A7 in anion-binding states provided insights into substrate recognition mechanisms potentially relevant to pendrin function in the SLC26 family.^[59] Animal models have been instrumental in dissecting tissue-specific roles of pendrin. Zebrafish slc26a4 mutants, generated via TALEN-mediated knockdown, recapitulate inner ear defects and ion homeostasis disruptions observed in human disease, providing a platform for high-throughput screening of anion transport modulators.^[60] In mice, conditional knockout approaches have revealed pendrin's involvement in airway physiology; a 2021 study using type II alveolar epithelial cell-specific ablation demonstrated that loss of Slc26a4 exacerbates allergic inflammation by disrupting the RhoA/SLC26A4 axis, leading to heightened cytokine release and mucus production.^[61] These models underscore pendrin's protective role in epithelial barrier function beyond the inner ear and thyroid. Omics approaches have refined pendrin's expression profile across cell types. Single-cell RNA sequencing (scRNA-seq) in 2023 profiled the adult mouse stria vascularis, confirming Slc26a4 enrichment in anion-transporting epithelial cells and revealing compensatory transcriptional changes in knockout models that link to endocochlear potential deficits.^[62]

Therapeutic Implications

Therapeutic strategies targeting pendrin (SLC26A4) are emerging, particularly for disorders like Pendred syndrome, where mutations impair anion transport in the thyroid, inner ear, and kidney. Gene therapy approaches, including CRISPR/Cas9-mediated exon skipping, have shown promise in preclinical models for correcting SLC26A4 mutations associated with hearing loss. For instance, in mouse models of DFNB4 caused by the SLC26A4 c.919-2A>G mutation, CRISPR editing restored vestibular function but was insufficient for full hearing recovery, highlighting the need for optimized strategies.^[63]^[64] Challenges in inner ear delivery persist, as viral vectors must navigate the blood-labyrinthine barrier while avoiding off-target effects and immune responses in this delicate structure.^[65] Pharmacological modulation of pendrin activity offers another avenue, with inhibitors demonstrating potential in airway and renal contexts. Tenidap, an anti-inflammatory drug, inhibits pendrin-mediated anion exchange in vitro, reducing activity by up to 50% at 0.1 mM concentrations, and has been explored for its effects on IL-13-induced airway inflammation in preclinical asthma models.^[66] For thyroid defects in Pendred syndrome, iodide supplementation mitigates goiter and hypothyroidism risk by compensating for impaired organification, as goiter severity correlates inversely with dietary iodide intake.^[67] Novel small-molecule pendrin inhibitors, such as those tested in murine models, attenuate airway hyperresponsiveness and mucin production in allergic asthma without the toxicity issues of earlier compounds like tenidap.^[68] Hearing restoration in Pendred syndrome relies primarily on cochlear implants, which provide effective auditory rehabilitation for severe-to-profound sensorineural hearing loss, improving speech perception in over 80% of pediatric cases.^[69] Emerging vestibular gene therapy, building on SLC26A4 mouse models where pendrin delivery preserved balance function, is advancing toward clinical trials, with 2025 preclinical data suggesting feasibility for inner ear-specific interventions.^[64] In airway diseases, anti-IL-13 biologics like lebrikizumab indirectly suppress pendrin expression by blocking IL-13/STAT6 signaling, which upregulates pendrin in asthmatic epithelium and contributes to mucus hypersecretion.^[70]^[71] Future prospects include small-molecule modulators to address renal acidosis linked to pendrin dysfunction, as pendrin facilitates bicarbonate reabsorption in intercalated cells, and its deficiency exacerbates acid-base imbalances in distal renal tubular acidosis.^[72] Personalized medicine approaches, utilizing functional assays like fluorometric ion transport measurements, enable variant-specific classification of SLC26A4 mutations, guiding tailored interventions such as targeted gene editing for residual-function alleles.^[73] These strategies emphasize pendrin's multifaceted role, with ongoing research prioritizing safe, organ-specific delivery to translate preclinical successes into clinical benefits.

References

[1]
https://doi.org/10.1038/ng1297-411
[2]
Mechanism of anion exchange and small-molecule inhibition of ...
Jan 6, 2024 · Pendrin is an anion transporter that exports I− or HCO3− in exchange for Cl−, and is important for maintaining the function of epithelial cells ...
[3]
https://doi.org/10.1073/pnas.071516798
[4]
https://www.ncbi.nlm.nih.gov/books/NBK549839/
[5]
Pendred syndrome is caused by mutations in a putative sulphate ...
Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet. 1997 Dec;17(4):411-22. ... SLC26A4 protein, human; Sulfate ...
[6]
Entry - #274600 - PENDRED SYNDROME; PDS - OMIM - (OMIM.ORG)
(1997) used the mapping of the Pendred syndrome gene ... (1997) used a positional cloning strategy to identify the gene (SLC26A4) mutated in Pendred syndrome.
[7]
https://omim.org/entry/274600
[8]
Selection of Diagnostically Significant Regions of the SLC26A4 ...
Nov 3, 2022 · The SLC26A4 gene is located in chromosome 7 (7:107,660,828-107,717,809; GRCh38 assembly), covers about 57 kb of genomic DNA and comprises 21 ...
[9]
SLC26A4-Related Sensorineural Hearing Loss - GeneReviews - NCBI
Apr 3, 2025 · Pendrin is expressed in a limited number of tissues, including the inner ear, thyroid, kidney, and lungs (where it is expressed in the ...Missing: choroid plexus
[10]
Transcriptional control of SLC26A4 is involved in Pendred syndrome ...
We have identified and characterized a key transcriptional regulatory element in the SLC26A4 promoter that binds FOXI1, a transcriptional activator of SLC26A4.
[11]
Human SLC26A4/Pendrin STAS domain is a nucleotide-binding ...
SLC26 family anion transport proteins are conserved throughout phylogeny from bacteria to humans [1], [2]. In prokaryotes and plants this family of proteins is ...
[12]
SLC26A4 | Homo sapiens gene - Alliance of Genome Resources
Located in apical plasma membrane and extracellular exosome. Implicated in Pendred Syndrome; autosomal recessive nonsyndromic deafness 4; and goiter. RGD ...Missing: hg38 | Show results with:hg38
[13]
SLC26A4 Gene - GeneCards | S26A4 Protein
SLC26A4 (Solute Carrier Family 26 Member 4) is a Protein Coding gene. Diseases associated with SLC26A4 include Pendred Syndrome and Deafness.
[14]
605646 - SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
The SLC26A4 gene encodes an anion transporter known as pendrin, which transports iodide and chloride (Everett et al., 1997; Scott et al., 1999).Missing: hg38 | Show results with:hg38
[15]
Pendrin - an overview | ScienceDirect Topics
Pendrin is key protein in the metabolic pathway of iodide metabolism and resides in the apical domain of thyroid follicular cells.<|control11|><|separator|>
[16]
The SLC26 Gene Family of Anion Transporters and Channels - NIH
SLC26 polypeptides are characterized by N-terminal cytoplasmic domains, 10–14 hydrophobic transmembrane spans, and C-terminal cytoplasmic STAS domains, and ...Missing: translational | Show results with:translational
[17]
Asymmetric pendrin homodimer reveals its molecular mechanism as ...
May 25, 2023 · Encoded by the gene SLC26A4, pendrin belongs to the solute carrier 26 (SLC26) family. ... The STAS domain modulates pendrin transport function.Missing: modifications | Show results with:modifications
[18]
N-glycosylation and topology of the human SLC26 family of anion ...
Loss of N-glycosylation sites on SLC26A4 has been reported not to alter its cell surface expression or targeting to the apical membrane but did change the ...
[19]
Analysis of Cellular Localization and Function of Carboxy-Terminal ...
It is possible that other post-translational modifications, such as glycosylation may have to occur together with phosphorylation in order for translocation to ...
[20]
TSH Regulates Pendrin Membrane Abundance and Enhances ...
TSH and forskolin rapidly increase pendrin abundance at the plasma membrane through the protein kinase A pathway in PCCL-3 rat thyroid cells.
[21]
Mechanism of anion exchange and small-molecule inhibition ... - NIH
Jan 6, 2024 · Pendrin (SLC26A4) is an anion exchanger that mediates bicarbonate (HCO 3 − ) exchange for chloride (Cl − ) and is crucial for maintaining pH and salt ...
[22]
STAS domain structure and function | Request PDF - ResearchGate
Aug 6, 2025 · Pendrin belongs to the SLC26 anion transporter protein family. The SLC26 proteins were originally predicted to contain ~12 transmembrane (TM) ...
[23]
TSH Regulates Pendrin Membrane Abundance and Enhances ... - NIH
These results demonstrate that pendrin translocates to the membrane in response to TSH and suggest that it may have a physiological role in apical iodide ...
[24]
Systemic Roles of SLC26A4 in Various Organs - MDPI
As a multiple-ion transporter, SLC26A4 is involved in the maintenance of hearing function, renal function, blood pressure, and hormone and pH regulation.Missing: choroid plexus
[25]
Sodium-Iodide Symporter NIS and Pendrin in Iodide Homeostasis of ...
Mar 1, 2009 · The mature NIS protein is approximately 87 kDa in size and has three asparagine-linked glycosylation sites (1). Glycosylation does not seem ...<|control11|><|separator|>
[26]
Pendred syndrome and iodide transport in the thyroid - ScienceDirect
In the thyroid, pendrin localizes to the apical membrane of thyrocytes, where it may be involved in mediating iodide efflux. Loss-of-function mutations in the ...
[27]
Influence of dietary iodine deficiency on the thyroid gland in Slc26a4 ...
Jun 20, 2011 · We hypothesized that the absence of goiter and hypothyroidism in Slc26a4-/- mice was due to a sufficient iodine intake, and that goiter and ...Missing: knockout uptake
[28]
Single-cell RNA-sequencing of stria vascularis cells in the adult ...
Jun 15, 2023 · In the inner ear, pendrin is expressed in the epithelial cells, transports bicarbonate (HCO3−) into the endolymph, and maintains endolymphatic ...<|control11|><|separator|>
[29]
Mouse Models for Pendrin-Associated Loss of Cochlear and ... - NIH
Pendrin in the inner ear functions mainly as a Cl−/HCO3− exchanger which secretes HCO3− into endolymph and thereby elevates the endolymphatic pH [34, 37, 38].
[30]
Integration of Human and Mouse Genetics Reveals Pendrin ... - NIH
In the inner ear, the work on Slc26a4 null mice reveals the role of pendrin in regulating the pH of endolymphatic fluids through secretion of HCO3−ions [11].
[31]
Potassium Ion Movement in the Inner Ear: Insights from Genetic ...
This review focuses on cellular ion transport mechanisms in the stria vascularis that generate the major electrochemical gradients for sensory transduction.
[32]
The Renal Physiology of Pendrin-Positive Intercalated Cells - PMC
In particular, pendrin regulates blood pressure and NaCl balance by mediating Cl− absorption, and by regulating epithelial Na+ channel (ENaC)-dependent Na+ ...
[33]
https://pmc.ncbi.nlm.nih.gov/articles/PMC7474261/
[34]
SLC26A4 - Pendrin - Homo sapiens (Human) | UniProtKB | UniProt
An autosomal recessive disorder characterized by congenital sensorineural hearing loss in association with thyroid goiter.
[35]
Characterization and semiquantitative analyses of pendrin ...
In conclusion, we show that pendrin expressed by the human thyroid gland is a mainly monomeric glycoprotein and that the level of expression of pendrin, ...Missing: quantitative comparison
[36]
Dynamic regulation of airway surface liquid pH by TMEM16A and ...
Nov 15, 2023 · In this study we were able to increase ASL pH in the absence of a functional CFTR, using two alternative transporters, TMEM16A and SLC26A4.
[37]
Pendrin Mediates Bicarbonate Secretion and Enhances Cystic ...
Apr 28, 2018 · We conclude that pendrin mediates most HCO 3 − secretion across airway surface epithelium during inflammation and enhances electrogenic Cl − secretion via CFTR.
[38]
The Significance of Hypothiocyanite Production via the Pendrin ...
Nonciliated airway epithelial cells are likely the main pendrin-expressing cells when stimulated by IL-4/IL-13, because pendrin expression is upregulated in the ...
[39]
Interleukin-13 increases pendrin abundance to the cell surface in ...
Emerging data suggest that an increased expression of pendrin in airway epithelia is associated with elevated airway hyperreactivity in asthma. Here, we ...Missing: inducible inflammation
[40]
Expression Profiling of the Solute Carrier Gene Family in the Mouse ...
A major function of the choroid plexus is to secret CSF, which is accomplished by active transport of small ions (e.g., Na+, Cl-, bicarbonate) across the ...
[41]
The Slc26a4 transporter functions as an electroneutral Cl−/I ... - NIH
To study the role of Slc26a4 in vivo we examined the expression of Slc26a4 in mouse salivary glands. Figure 5A shows that Slc26a6, Slc26a4 and Na+–I ...
[42]
Pendrin - an overview | ScienceDirect Topics
In addition to its expression in the thyroid and inner ear, SLC26A4 mRNA is readily found in the kidney,45 in particular in the renal cortex, and nephron ...
[43]
Importance of SLC26 Transmembrane Anion Exchangers in Sperm ...
In this review, we will focus on SLC26s contributions to ionic- and pH-dependent processes during sperm post-testicular maturation.
[44]
PVD9902, a porcine vas deferens epithelial cell line that exhibits ...
Jan 18, 2006 · SLC26A4 (pendrin) and SLC26A6 (a C1⫺/formate exchanger, CFEX that is also known as a putative anion transporter-1; PAT-1) in separate ...
[45]
Pendred Syndrome - StatPearls - NCBI Bookshelf - NIH
Jun 2, 2025 · Mutations in the SLC26A4 gene, which encodes the pendrin protein, disrupt ion transport processes vital to cochlear and thyroid function.
[46]
SLC26A4 mutation spectrum associated with DFNB4 deafness and ...
Mar 13, 2009 · We show that SLC26A4 mutations are a common cause of genetic deafness among Pakistanis and their distinctive spectrum lends itself to hierarchical detection ...
[47]
The Epithelial Anion Transporter Pendrin Is Induced by Allergy and ...
The Th2 cytokines IL-13 and IL-4 are produced during allergic responses and cause increases in airway epithelial cell mucus, electrolyte and water secretion ...Missing: inducible | Show results with:inducible
[48]
Identification of pendrin as a common mediator for mucus production ...
May 1, 2008 · Pendrin can induce mucus production in airway epithelial cells and may be a therapeutic target candidate for bronchial asthma and COPD.Missing: hypersecretion | Show results with:hypersecretion
[49]
Custom Next‐Generation Sequencing Identifies Novel Mutations ...
Jan 8, 2022 · We report eight pathogenic variants, four of which are novel in patients with isolated hearing impairment, hearing impairment, and renal tubular acidosis.<|control11|><|separator|>
[50]
Identification of PENDRIN (SLC26A4) Mutations in Patients With ...
Impaired thyroid function is postulated to be due to reduced iodine organification, leading to the development of an enlarged gland with and without altered ...Missing: knockout | Show results with:knockout
[51]
[PDF] Mutation Screening and Functional Study of SLC26A4 in Chinese ...
Pendrin, the protein encoded by the Pendred syndrome gene. (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells ...
[52]
Analysis of SLC26A4, FOXI1, and KCNJ10 Gene Variants in ... - MDPI
Dec 6, 2022 · Pathogenic variants in the SLC26A4, FOXI1, and KCNJ10 genes are associated with hearing loss (HL) and specific inner ear abnormalities (DFNB4).
[53]
Different Rates of the SLC26A4-Related Hearing Loss in Two ...
Dec 17, 2021 · 919-2A>G was the highest frequency SLC26A4 mutation (62.4%) followed by c.2168A>G (p.His723Arg) (26.1%). Various sets of the SLC26A4 mutations ...
[54]
Variants in gene SLC26A4 - ClinVar Miner - The University of Utah
ClinVar version: 2025-06-30. If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the ...
[55]
Novel genetic determinants contribute to hearing loss in a central ...
Mar 22, 2025 · The present investigation confirms the role of SLC26A4 in determining hearing loss with EVA, identifies novel genes in this pathophysiological context.Missing: risk | Show results with:risk<|separator|>
[56]
Modeling SLC26A4 Associated Hearing Loss Using Zebrafish as a ...
To model the human condition, slc26a4 mutations in zebrafish were generated via transcription activator like effector nucleases (TALENs) at the site of the the ...
[57]
Single-cell RNA-sequencing of stria vascularis cells in the adult ...
Jun 15, 2023 · The primary pathological alterations of Pendred syndrome are endolymphatic pH acidification and luminal enlargement of the inner ear.
[58]
Gene expression profiling of airway epithelium in Mycobacterium ...
Future single-cell and spatial transcriptome analysis will further elucidate the roles of key genes, including SLC26A4, in the pathogenesis of NTM-LD. In ...
[59]
CRISPR/Cas9-mediated exon skipping to restore premature ...
Sep 4, 2024 · Our findings highlight the necessity for alternative genetic editing strategies to address hearing loss caused by the SLC26A4 c.919-2 A > G mutation.
[60]
Gene therapy for hereditary hearing loss by SLC26A4 mutations in ...
Sep 23, 2019 · Our study illustrates the feasibility of gene therapy for pendrin-related hearing loss, suggests differences in the requirement of pendrin between the cochlea ...
[61]
Gene therapy advancements for the treatment of acquired ... - Frontiers
This review provides a comprehensive analysis of the latest developments in gene therapy for hearing loss.
[62]
Effect of Known Inhibitors of Ion Transport on Pendrin (SLC26A4 ...
May 9, 2016 · A review of the literature regarding the ability of some compounds (namely several known inhibitors of ion transport) to block pendrin activity ...
[63]
Pendred syndrome and iodide transport in the thyroid - PubMed - NIH
This review discusses the controversies surrounding the potential role of pendrin in mediating apical iodide efflux into the lumen of thyroid follicles, and ...
[64]
Novel pendrin inhibitor attenuates airway hyperresponsiveness and ...
Novel pendrin inhibitor attenuates airway hyperresponsiveness and mucin expression in experimental murine asthma.Missing: tenidap | Show results with:tenidap
[65]
Cochlear implantation in patients with Pendred syndrome - PubMed
May 19, 2021 · Cochlear implantation is an effective and successful treatment for severe-to-profound hearing loss in children with Pendred syndrome.
[66]
Interleukin-Mediated Pendrin Transcriptional Regulation in Airway ...
A comparative study of tenidap, a cytokine-modulating anti-rheumatic drug, and diclofenac in rheumatoid arthritis: A 24-week analysis of a 1-year clinical trial ...
[67]
Frontiers | The efficacy and safety of IL-13 inhibitors in atopic dermatitis
Jul 26, 2022 · Antagonizing IL-13 with lebrikizumab and tralokinumab have demonstrated encouraging clinical efficacy against moderate-to-severe AD with excellent safety ...
[68]
Regulation of Blood Pressure and Salt Balance By Pendrin-Positive ...
Feb 3, 2022 · Pendrin is an electroneutral, Cl−/HCO3− exchanger found in the thyroid, inner ear, kidney, and adrenal gland. In kidney, pendrin mediates Cl− ...
[69]
Functional assessment of allelic variants in the SLC26A4 gene ...
Nov 25, 2008 · To assay the transport function of the SLC26A4 allelic variants, we used a recently described fast fluorometric method for measuring ...Sign Up For Pnas Alerts · Results · Discussion
[70]
SLC26A4 C.317C > A Variant: Functional Analysis and Patient ... - NIH
Apr 22, 2025 · SLC26A4 is the second most common cause of hereditary hearing loss worldwide. This gene predominantly harbors pathogenic variants, ...Missing: personalized | Show results with:personalized